Gray-blue discoloration of the proximal nail beds.
Weinberg LS, Arreola A, Mervak JE.
JAAD Case Rep. 2023 Apr 25;35:126-128. doi: 10.1016/j.jdcr.2023.04.004. eCollection 2023 May.
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.
Chari A, Krishnan A, Rasche L, Ye JC, Garfall A, Popat R, Lipe B, Qin X, Campagna M, Masterson T, Tomlinson C, Hilder B, Tolbert J, Renaud T, Smit MD, Gray K, Kane C, Heuck C, van de Donk NWCJ.
Clin Lymphoma Myeloma Leuk. 2024 Oct;24(10):665-693.e14. doi: 10.1016/j.clml.2024.05.003. Epub 2024 May 15.
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
COVIDSurg Collaborative, GlobalSurg Collaborative.
Br J Surg. 2021 Sep 27;108(9):1056-1063. doi: 10.1093/bjs/znab101.
Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity.
Sánchez AR, Rogers RS 3rd, Sheridan PJ.
Int J Dermatol. 2004 Oct;43(10):709-15. doi: 10.1111/j.1365-4632.2004.02108.x.
The nail in the elderly.
Baran R.
Clin Dermatol. 2011 Jan-Feb;29(1):54-60. doi: 10.1016/j.clindermatol.2010.07.008.
Dasatinib-Induced Transverse Melanonychia.
Tyagi M, Gaurav V, Kaur J.
Skin Appendage Disord. 2023 Dec;9(6):449-452. doi: 10.1159/000531928. Epub 2023 Aug 21.
Dermatoscopy of melanoma according to type, anatomic site and stage.
Lallas A, Paschou E, Manoli SM, Papageorgiou C, Spyridis I, Liopyris K, Bobos M, Moutsoudis A, Lazaridou E, Apalla Z.
Ital J Dermatol Venerol. 2021 Jun;156(3):274-288. doi: 10.23736/S2784-8671.20.06784-X. Epub 2020 Dec 14.
Silver Toxicity.
Steck MB, Murray BP.
2024 Oct 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.
COVIDSurg Collaborative; GlobalSurg Collaborative.
Anaesthesia. 2021 Jun;76(6):748-758. doi: 10.1111/anae.15458. Epub 2021 Mar 9.
Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma.
Catamero D, Ray C, Purcell K, Leahey S, Esler E, Rogers S, Hefner K, O'Rourke L, Gray K, Tolbert J, Renaud T, Patel S, Hannemann L, Shenoy S.
Semin Oncol Nurs. 2024 Oct;40(5):151712. doi: 10.1016/j.soncn.2024.151712. Epub 2024 Aug 17.
